Mary E. Hamby

2.6k total citations
25 papers, 1.9k citations indexed

About

Mary E. Hamby is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Mary E. Hamby has authored 25 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Neurology and 8 papers in Physiology. Recurrent topics in Mary E. Hamby's work include Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Alzheimer's disease research and treatments (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Mary E. Hamby is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (9 papers), Alzheimer's disease research and treatments (6 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). Mary E. Hamby collaborates with scholars based in United States, Sweden and United Kingdom. Mary E. Hamby's co-authors include Michael V. Sofroniew, Ronald L. Klein, Michael A. King, James A. Hewett, Sandra J. Hewett, Edwin M. Meyer, William J. Ray, Celia Fernandez, Yan Ao and Stoyan Dimitrov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Scientific Reports.

In The Last Decade

Mary E. Hamby

24 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E. Hamby United States	16	569	541	466	306	281	25	1.9k
Souhel Najjar United States	21	621 1.1×	511 0.9×	587 1.3×	280 0.9×	646 2.3×	37	2.5k
David Martin United States	24	789 1.4×	746 1.4×	721 1.5×	264 0.9×	207 0.7×	42	2.6k
Shuichi Chiba Japan	21	278 0.5×	492 0.9×	346 0.7×	481 1.6×	356 1.3×	75	2.1k
Maria Gulinello United States	40	685 1.2×	946 1.7×	908 1.9×	514 1.7×	359 1.3×	81	3.7k
Carole Rovère France	32	562 1.0×	816 1.5×	571 1.2×	425 1.4×	178 0.6×	63	2.8k
Mária Nikodémová United States	24	855 1.5×	361 0.7×	258 0.6×	351 1.1×	198 0.7×	47	1.9k
Juliette Van Steenwinckel France	22	375 0.7×	292 0.5×	369 0.8×	454 1.5×	147 0.5×	42	1.6k
Michelle Potter United States	15	263 0.5×	667 1.2×	450 1.0×	311 1.0×	447 1.6×	22	2.0k
Janine Doorduin Netherlands	24	1.0k 1.8×	590 1.1×	570 1.2×	381 1.2×	1.1k 3.9×	92	3.1k

Countries citing papers authored by Mary E. Hamby

Since Specialization

Citations

This map shows the geographic impact of Mary E. Hamby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Hamby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Hamby more than expected).

Fields of papers citing papers by Mary E. Hamby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Hamby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Hamby. The network helps show where Mary E. Hamby may publish in the future.

Co-authorship network of co-authors of Mary E. Hamby

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Hamby. A scholar is included among the top collaborators of Mary E. Hamby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Hamby. Mary E. Hamby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cho, Eun-Ah, Kiran Pandey, Duc M. Duong, et al.. (2025). Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer's disease drug candidate CT1812. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(2). e70119–e70119. 1 indexed citations

Lizama, Britney N., Eun-Ah Cho, Gary C. Look, et al.. (2025). Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD). Scientific Reports. 15(1). 4256–4256. 3 indexed citations

Dyck, Christopher H. van, Adam P. Mecca, Ryan S. O’Dell, et al.. (2024). A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer’s disease. Alzheimer s Research & Therapy. 16(1). 20–20. 15 indexed citations

Kiehlbauch, Charles, et al.. (2024). Neuroprotective effect of Sigma-2 modulator CT2074 in a mouse model of ocular hypertension. Experimental Eye Research. 249. 110143–110143.

Lizama, Britney N., Claire Williams, Kiran Pandey, et al.. (2024). CT1812 biomarker signature from a meta‐analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease. Alzheimer s & Dementia. 20(10). 6860–6880. 4 indexed citations

Rehak, Courtney, et al.. (2021). Unbiased omics analyses of the sigma-2 antagonist CT1812 in age-related diseases and models. Investigative Ophthalmology & Visual Science. 62(8). 267–267. 2 indexed citations

Fernandez, Celia, et al.. (2019). The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease. Frontiers in Aging Neuroscience. 11. 14–14. 180 indexed citations

Hamby, Mary E., Giovanni Coppola, Yan Ao, et al.. (2012). Inflammatory Mediators Alter the Astrocyte Transcriptome and Calcium Signaling Elicited by Multiple G-Protein-Coupled Receptors. Journal of Neuroscience. 32(42). 14489–14510. 178 indexed citations

Uliasz, Tracy F., Mary E. Hamby, Nicole A. Jackman, James A. Hewett, & Sandra J. Hewett. (2011). Generation of Primary Astrocyte Cultures Devoid of Contaminating Microglia. Methods in molecular biology. 814. 61–79. 24 indexed citations

10.

Hamby, Mary E., James A. Hewett, & Sandra J. Hewett. (2010). Smad3‐dependent signaling underlies the TGF‐β1‐mediated enhancement in astrocytic iNOS expression. Glia. 58(11). 1282–1291. 21 indexed citations

11.

Hamby, Mary E. & Michael V. Sofroniew. (2010). Reactive Astrocytes As Therapeutic Targets for CNS Disorders. Neurotherapeutics. 7(4). 494–506. 274 indexed citations

12.

O'Connor, Mary‐Frances, Hyong Jin Cho, J. David Creswell, et al.. (2009). To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers. Brain Behavior and Immunity. 23(7). 887–897. 434 indexed citations

13.

Hamby, Mary E., Volkan Coskun, & Yi Eve Sun. (2008). Transcriptional regulation of neuronal differentiation: The epigenetic layer of complexity. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1779(8). 432–437. 30 indexed citations

14.

Hamby, Mary E., et al.. (2007). TGFβ1 and TNFα potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2. Neurochemistry International. 52(6). 962–971. 24 indexed citations

15.

Hamby, Mary E., James A. Hewett, & Sandra J. Hewett. (2007). TGF-β1 reduces the heterogeneity of astrocytic cyclooxygenase-2 and nitric oxide synthase-2 gene expression in a stimulus-independent manner. Prostaglandins & Other Lipid Mediators. 85(3-4). 115–124. 12 indexed citations

16.

Hamby, Mary E., James A. Hewett, & Sandra J. Hewett. (2006). TGF‐β1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS‐2. Glia. 54(6). 566–577. 58 indexed citations

17.

Hamby, Mary E., Tracy F. Uliasz, Sandra J. Hewett, & James A. Hewett. (2005). Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. Journal of Neuroscience Methods. 150(1). 128–137. 98 indexed citations

18.

Klein, Ronald L., et al.. (2002). Measurements of vector-derived neurotrophic factor and green fluorescent protein levels in the brain. Methods. 28(2). 286–292. 35 indexed citations

19.

Klein, Ronald L., Michael A. King, Mary E. Hamby, & Edwin M. Meyer. (2002). Dopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra. Human Gene Therapy. 13(5). 605–612. 175 indexed citations

20.

Klein, Ronald L., Mary E. Hamby, Yan Gong, et al.. (2002). Dose and Promoter Effects of Adeno-Associated Viral Vector for Green Fluorescent Protein Expression in the Rat Brain. Experimental Neurology. 176(1). 66–74. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact